108 related articles for article (PubMed ID: 28343079)
1. Population model of bladder motion and deformation based on dominant eigenmodes and mixed-effects models in prostate cancer radiotherapy.
Rios R; De Crevoisier R; Ospina JD; Commandeur F; Lafond C; Simon A; Haigron P; Espinosa J; Acosta O
Med Image Anal; 2017 May; 38():133-149. PubMed ID: 28343079
[TBL] [Abstract][Full Text] [Related]
2. Modelling individual geometric variation based on dominant eigenmodes of organ deformation: implementation and evaluation.
Söhn M; Birkner M; Yan D; Alber M
Phys Med Biol; 2005 Dec; 50(24):5893-908. PubMed ID: 16333162
[TBL] [Abstract][Full Text] [Related]
3. Is Dose Deformation-Invariance Hypothesis Verified in Prostate IGRT?
Simon A; Le Maitre A; Nassef M; Rigaud B; Castelli J; Acosta O; Haigron P; Lafond C; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):830-838. PubMed ID: 28244420
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric treatment course simulation based on a statistical model of deformable organ motion.
Söhn M; Sobotta B; Alber M
Phys Med Biol; 2012 Jun; 57(12):3693-709. PubMed ID: 22614733
[TBL] [Abstract][Full Text] [Related]
5. Automatic bladder segmentation on CBCT for multiple plan ART of bladder cancer using a patient-specific bladder model.
Chai X; van Herk M; Betgen A; Hulshof M; Bel A
Phys Med Biol; 2012 Jun; 57(12):3945-62. PubMed ID: 22643320
[TBL] [Abstract][Full Text] [Related]
6. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy.
Dowling JA; Lambert J; Parker J; Salvado O; Fripp J; Capp A; Wratten C; Denham JW; Greer PB
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e5-11. PubMed ID: 22330995
[TBL] [Abstract][Full Text] [Related]
7. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
8. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
[TBL] [Abstract][Full Text] [Related]
9. Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions.
Murthy V; Shukla P; Adurkar P; Master Z; Mahantshetty U; Shrivastava S
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):119-24. PubMed ID: 22300567
[TBL] [Abstract][Full Text] [Related]
10. Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy.
Peng C; Ahunbay E; Chen G; Anderson S; Lawton C; Li XA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):909-14. PubMed ID: 20732764
[TBL] [Abstract][Full Text] [Related]
11. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
[TBL] [Abstract][Full Text] [Related]
12. A probabilistic deep learning model of inter-fraction anatomical variations in radiotherapy.
Pastor-Serrano O; Habraken S; Hoogeman M; Lathouwers D; Schaart D; Nomura Y; Xing L; Perkó Z
Phys Med Biol; 2023 Apr; 68(8):. PubMed ID: 36958058
[No Abstract] [Full Text] [Related]
13. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
[TBL] [Abstract][Full Text] [Related]
14. Development of multiorgan finite element-based prostate deformation model enabling registration of endorectal coil magnetic resonance imaging for radiotherapy planning.
Hensel JM; Ménard C; Chung PW; Milosevic MF; Kirilova A; Moseley JL; Haider MA; Brock KK
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1522-8. PubMed ID: 17674983
[TBL] [Abstract][Full Text] [Related]
15. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
[TBL] [Abstract][Full Text] [Related]
16. DMLC tracking and gating can improve dose coverage for prostate VMAT.
Colvill E; Poulsen PR; Booth JT; O'Brien RT; Ng JA; Keall PJ
Med Phys; 2014 Sep; 41(9):091705. PubMed ID: 25186380
[TBL] [Abstract][Full Text] [Related]
17. Bladder dose-surface maps and urinary toxicity: Robustness with respect to motion in assessing local dose effects.
Palorini F; Botti A; Carillo V; Gianolini S; Improta I; Iotti C; Rancati T; Cozzarini C; Fiorino C
Phys Med; 2016 Mar; 32(3):506-11. PubMed ID: 27053449
[TBL] [Abstract][Full Text] [Related]
18. Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers.
van der Wielen GJ; Mutanga TF; Incrocci L; Kirkels WJ; Vasquez Osorio EM; Hoogeman MS; Heijmen BJ; de Boer HC
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1604-1611.e3. PubMed ID: 19028284
[TBL] [Abstract][Full Text] [Related]
19. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
[TBL] [Abstract][Full Text] [Related]
20. Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration.
Thörnqvist S; Petersen JB; Høyer M; Bentzen LN; Muren LP
Acta Oncol; 2010 Oct; 49(7):1023-32. PubMed ID: 20831491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
